Increased deoxycytidine kinase activity by etoposide in L1210 murine leukemic cells

Biol Pharm Bull. 1996 Oct;19(10):1382-3. doi: 10.1248/bpb.19.1382.

Abstract

Deoxycytidine kinase (dCK) is a rate-limiting enzyme for the activation of ara-C. It is responsible for the phosphorylation of ara-C which is widely used in the treatment of leukemia. We examined the effect of etoposide on dCK in L1210 cells and found that incubation with 10 microM etoposide for 1 h increased dCK activity to 170% of the control. This effect of etoposide on dCK activity was concentration-dependent up to at least 100 microM of the substance.

MeSH terms

  • Animals
  • Cytarabine / metabolism
  • Deoxycytidine Kinase / metabolism*
  • Etoposide / pharmacology*
  • Leukemia L1210 / enzymology*
  • Methotrexate / pharmacology
  • Mice
  • Phosphorylation

Substances

  • Cytarabine
  • Etoposide
  • Deoxycytidine Kinase
  • Methotrexate